We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$27.8B
AUM Growth
+$1.24B
Cap. Flow
-$912M
Cap. Flow %
-3.28%
Top 10 Hldgs %
21.54%
Holding
2,538
New
369
Increased
762
Reduced
883
Closed
318

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$74.4M
2
LIN icon
Linde
LIN
+$64.8M
3
UNH icon
UnitedHealth
UNH
+$58.1M
4
FHN icon
First Horizon
FHN
+$51.3M
5
PH icon
Parker-Hannifin
PH
+$46.3M

Sector Composition

Rank Sector Weight
1 Technology 23.71%
2 Financials 16.15%
3 Healthcare 11.99%
4 Consumer Discretionary 11.13%
5 Communication Services 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFBS
2001
ServisFirst Bancshares
SFBS
$4.79B
$88K ﹤0.01%
+1,300
New +$86K
UNFI icon
2002
United Natural Foods
UNFI
$3.01B
$88K ﹤0.01%
2,400
FBRX icon
2003
Forte Biosciences
FBRX
$1.12B
$87K ﹤0.01%
+104
New +$93.7K
PI icon
2004
Impinj
PI
$3.89B
$87K ﹤0.01%
+1,700
New +$87.5K
PLRX icon
2005
Pliant Therapeutics
PLRX
$67.5M
$87K ﹤0.01%
3,000
+400
+15% +$12.5K
FROG icon
2006
JFrog
FROG
$9.71B
$86K ﹤0.01%
+1,900
New +$85.6K
TW icon
2007
Tradeweb Markets
TW
$21.3B
$86K ﹤0.01%
1,020
FOR icon
2008
Forestar Group
FOR
$1.44B
$85K ﹤0.01%
4,100
SEIC icon
2009
SEI Investments
SEIC
$11.9B
$85K ﹤0.01%
1,381
-468,000
-100% -$29.2M
ZG icon
2010
Zillow
ZG
$7.02B
$85K ﹤0.01%
699
-5,525
-89% -$682K
ARDX icon
2011
Ardelyx
ARDX
$1.24B
$84K ﹤0.01%
11,120
KROS icon
2012
Keros Therapeutics
KROS
$199M
$84K ﹤0.01%
2,000
+200
+11% +$10.8K
TNXP icon
2013
Tonix Pharmaceuticals
TNXP
$157M
0
ZVRA icon
2014
Zevra Therapeutics
ZVRA
$563M
$84K ﹤0.01%
+6,600
New +$70.9K
CLPT icon
2015
ClearPoint Neuro
CLPT
$423M
$83K ﹤0.01%
+4,400
New +$85K
OUST icon
2016
Ouster
OUST
$2.29B
$83K ﹤0.01%
+670
New +$71.5K
AMPH icon
2017
Amphastar Pharmaceuticals
AMPH
$825M
$82K ﹤0.01%
+4,100
New +$77.3K
CGEM icon
2018
Cullinan Oncology
CGEM
$1.05B
$82K ﹤0.01%
3,200
ORMP icon
2019
Oramed Pharmaceuticals
ORMP
$165M
$82K ﹤0.01%
+6,200
New +$70.9K
JNCE
2020
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$82K ﹤0.01%
12,200
CURI icon
2021
CuriosityStream
CURI
$139M
$81K ﹤0.01%
+6,000
New +$77.5K
UAVS icon
2022
AgEagle Aerial Systems
UAVS
$41.4M
$81K ﹤0.01%
+16
New +$87.7K
NOTV
2023
DELISTED
Inotiv
NOTV
$80K ﹤0.01%
+3,000
New +$75.1K
SIRI icon
2024
SiriusXM
SIRI
$10B
$80K ﹤0.01%
1,235
-3,890
-76% -$244K
GCMG icon
2025
GCM Grosvenor
GCMG
$737M
$79K ﹤0.01%
+7,600
New +$89.8K

Similar funds

STRS Ohio's Q2 2021 Portfolio in Review

As of Q2 2021, STRS Ohio held 2,538 positions worth $27.8B, up 4.7% from $26.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

STRS Ohio withdrew a net $912M in Q2 2021, closing 318 positions and reducing 883 holdings. Its most notable exit was Linde, an estimated $64.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, STRS Ohio opened a new position in Cogent Communications worth $6.83M.

  • STRS Ohio's largest Q2 2021 buy was Cogent Communications: 88,900 shares worth $6.83M.
  • STRS Ohio added most to Snap in Q2 2021, an estimated $34.6M increase.
  • STRS Ohio's biggest Q2 2021 reduction was Apple, cutting an estimated $74.4M.
  • STRS Ohio fully exited Linde in Q2 2021, selling an estimated $64.8M.
  • STRS Ohio's ten largest holdings make up 22% of its $27.8B portfolio in Q2 2021.
  • STRS Ohio opened 369 new positions and closed 318 in Q2 2021.
  • STRS Ohio's portfolio value rose 4.7% quarter-over-quarter to $27.8B.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.